6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan, cepharanthin, cepharanthine

| Name | Cepharanthine | ||
| PubChem CID | 10206 | ||
| Molecular Weight | 606.7g/mol | ||
| Synonyms |
6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan, cepharanthin, cepharanthine |
||
| Formula | C₃₇H₃₈N₂O₆ | ||
| SMILES | CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3 | ||
| InChI | 1S/C37H38N2O6/c1-38-13-11-24-18-31(41-4)33-20-27(24)28(38)16-23-7-10-30(40-3)32(17-23)44-26-8-5-22(6-9-26)15-29-35-25(12-14-39(29)2)19-34-36(37(35)45-33)43-21-42-34/h5-10,17-20,28-29H,11-16,21H2,1-4H3/t28-,29+/m1/s1 | ||
| InChIKey | YVPXVXANRNDGTA-WDYNHAJCSA-N | ||
| CAS Number | 481-49-2 | ||
| ChEMBL ID | CHEMBL449782 | ||
| ChEBI ID | CHEBI:3546 | ||
| Herb ID | HBIN020124 | ||
| Drug Bank ID | DB16824 | ||
| KEGG ID | C09391 | ||
| Toxicity | Organism | Test Type | Route(Dose) |
| rat | LD50 | intraperitoneal(165 mg/kg) | |
| mouse | LD50 | intraperitoneal(254 mg/kg) | |
| rat | LD50 | oral(322 mg/kg) | |
| Structure |
Download
2D
MOL
3D
MOL
|
||
| Chineses Pinyin | BaiYaoZi | ||
| Use Part | Tuberoid | ||
| Habitat | JiangSu, AnHui, ZheJiang, JiangXi, FuJian, TaiWan, HuNan, GuangDong, GuangXi, GuiZhou | ||
| Flavor | Bitter, Pungent | ||
| Meridian Tropism | Lung, Stomach | ||
| Chineses Pinyin | DiBuRong | ||
| Use Part | Tuber | ||
| Habitat | HuNan, GuangDong, GuangXi, GuiZhou | ||
| Flavor | Bitter | ||
| Meridian Tropism | Stomach, Lung, Liver | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Ranunculales
-->Family: Menispermaceae
-->Genus: Stephania
-->Species: Stephania epigaea
|
||
| Chineses Pinyin | JinXianDiaoWuGui | ||
| Use Part | Root tuber | ||
| Habitat | Shaanxi, GanSu, QingHai, NingXia, XinJiang, ZheJiang, JiangSu, TaiWan, SiChuan, GuiZhou, YunNan, XiZang, ChongQing, BeiJing, TianJin, ShanDong, JiangSu, ShangHai, GuangDong, HaiNan, FuJian, Hongkong | ||
| Flavor | Bitter | ||
| Chineses Pinyin | TaiWanQianJinTeng | ||
| Use Part | Rhizome | ||
| Habitat | TaiWan | ||
| Flavor | Sweet | ||
| Meridian Tropism | Liver, Stomach | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Ranunculales
-->Family: Menispermaceae
-->Genus: Stephania
-->Species: Stephania sasaki
|
||
| Chineses Pinyin | QianJinTeng | ||
| Flavor | Pungent; Bitter | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Ranunculales
-->Family: Menispermaceae
-->Genus: Stephania
-->Species: Stephania japonica
|
||
| Pair Name | Cepharanthine, Epirubicin | |||
| Partner Name | Epirubicin | |||
| Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
| Biological Phenomena | Induction-->Mitochondrial fission and apoptosis | |||
| Gene Regulation | Up-regulation | Cleavage | PARP1 | hsa142 |
| Up-regulation | Cleavage | CASP3 | hsa836 | |
| Up-regulation | Expression | CYCS | hsa54205 | |
| Up-regulation | Expression | LINC01554 | KEGG ID N.A. | |
| Up-regulation | Expression | MFF | hsa56947 | |
| Down-regulation | Expression | MFN1 | hsa55669 | |
| Down-regulation | Expression | MFN2 | hsa9927 | |
| Down-regulation | Expression | OPA1 | hsa4976 | |
| Down-regulation | Phosphorylation | DNM1L | hsa10059 | |
| Up-regulation | Expression | PINK1 | hsa65018 | |
| Up-regulation | Expression | PRKN | hsa5071 | |
| Up-regulation | Expression | SQSTM1 | hsa8878 | |
| Up-regulation | Expression | MAP1LC3B | hsa81631 | |
| Up-regulation | Expression | CFL1 | hsa1072 | |
| Down-regulation | Phosphorylation | LIMK1 | hsa3984 | |
| In Vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 |
| BT-549 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_1092 | |
| In Vivo Model | MDA-MB-231 cells were suspended in a 1:1 ratio in DMEM medium with a Matrigel basement membrane matrix . Cells (4×10⁷) were inoculated in the right legs of mice. | |||
| Result | Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis | |||
| Pair Name | Cepharanthine, S-1 | |||
| Partner Name | S-1 | |||
| Disease Info | [ICD-11: 2B66.0] | Oral squamous cell carcinoma | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Down-regulation | Expression | DPYD | hsa1806 |
| Down-regulation | Expression | TYMS | hsa7298 | |
| In Vitro Model | HSC-2 | Oral cavity squamous cell carcinoma | Homo sapiens (Human) | CVCL_1287 |
| B88 | B88 cells were isolated from an OSCC patient | / | N.A. | |
| In Vivo Model | B88 or HSC2 cells (1×10⁶) were suspended in 0.1 mL of serum-free medium and injected into the subcutaneous tissue of 5-week-old nude mice. | |||
| Result | Combined therapy of cepharanthine and S-1 exerted antitumor effects on human OSCC xenografts markedly and significantly induced apoptotic cells in tumors treated with cepharanthine plus S-1. | |||
| Pair Name | Cepharanthine, Cisplatin | |||
| Partner Name | Cisplatin | |||
| Disease Info | [ICD-11: 2B70] | Esophageal cancer | Investigative | |
| Biological Phenomena | Induction-->Blockade of cell cycle in G2/M phase | |||
| Gene Regulation | Up-regulation | Expression | CDKN1A | hsa1026 |
| Up-regulation | Expression | TP53 | hsa7157 | |
| Up-regulation | Cleavage | PARP1 | hsa142 | |
| Down-regulation | Expression | BCL2 | hsa596 | |
| Up-regulation | Expression | BAX | hsa581 | |
| Up-regulation | Cleavage | CASP3 | hsa836 | |
| Up-regulation | Cleavage | CASP9 | hsa842 | |
| Up-regulation | Expression | APAF1 | hsa317 | |
| Up-regulation | Expression | CYCS | hsa54205 | |
| Down-regulation | Expression | ABCB1 | hsa5243 | |
| Up-regulation | Phosphorylation | MAPK8 | hsa5599 | |
| Up-regulation | Phosphorylation | JUN | hsa3725 | |
| In Vitro Model | Eca-109 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_6898 |
| In Vivo Model | Eca109 (3×10⁶) and Eca109/CDDP cells were injected subcutaneously (s.c.) into the flanks of mice. | |||
| Result | Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals | |||
| No. | Title | Href |
|---|---|---|
| 1 | Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis. Acta Pharmacol Sin. 2022 Jan;43(1):177-193. doi: 10.1038/s41401-021-00715-3. | Click |
| 2 | Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Anticancer Res. 2009 Apr;29(4):1263-70. | Click |
| 3 | Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals. Oncotarget. 2017 Nov 27;8(67):111144-111160. doi: 10.18632/oncotarget.22676. | Click |